Ahjay - i am surprise that we were the only people that submitted question - as for me i ask the following:Do you have any idea on timeframes from preclinical Phase to late stage for IMP 761?How will this be funded ?Any forwrd intention in diluting stock to raise capital.If ELFI 321 AIPAC (Chemo-IO Combo) Metastatic Breast Cancer result are compelling 2H19 what is the time frame on commercialization and generating an income ?To me, my focus is still at this stage ELFI 321 AIPAC trail and commercialization- MV stated he will update further news on the next webcast, that in my opinion will drive the share price.
The actual web cast is very technical so i will view again tomorrow on the company web page
ASX vs NASDAQ, page-103
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.020(6.56%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 28.5¢ | $913.3K | 3.099M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 124895 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 30287 | 2 |
View Market Depth
| Last trade - 16.10pm 21/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
